On March 3rd, all Floridians interested in learning about the use of biomarkers in Alzheimer’s research are invited to attend “Entangled: Tau, Alzheimer’s and Brain Health,” a free, virtual program of the Alzheimer’s Association.
To start the program off, keynote speaker Rodney Guttmann, Ph.D., will discuss the importance of biomarker research for identifying Alzheimer’s disease, to be followed by a presentation on “Healthy Living for the Brain and Body” by Alzheimer’s community educator Andre Hall.
“Accumulation of the tau protein into neurofibrillary tangles in neurons is a major pathological hallmark of Alzheimer’s disease,” said Guttmann. “While it has been long understood that tau changes are likely key to unlocking future therapies and diagnostic tools, it is only with an improved ability to identify, characterize and quantify these changes to tau that such a future can be realized.”
Guttmann, a biology professor at the University of West Florida, obtained his Ph.D. in pharmacology from the University of Alabama at Birmingham. His research includes biomarker assay development with a major focus on Alzheimer’s disease and neurodegeneration.
Alzheimer’s disease is the sixth-leading cause of death in the United States. More than five million Americans are living with the disease, the Alzheimer’s Association reports, including more than 580,000 Floridians.
“We are excited to partner with Dr. Guttmann to bring awareness to the biomarker research that is happening right here in Florida,” said Katie Fahrenbruch, program manager for the Alzheimer’s Association. “Biomarkers for Alzheimer’s disease and brain health are important discussions for us to have right now, as the number of people affected by Alzheimer’s only continues to climb.”
“Entangled: Tau, Alzheimer’s and Brain Health” will begin at 1 PM EST, Wednesday, March 3. The program is free to attend. To register, visit www.bit.ly/AlzEntangled or call the Alzheimer’s Association 24/7 Helpline at 800-272-3900.